TLDR:
- Lux Capital’s Josh Wolfe is bullish on investing in AI sectors, particularly in biology and robotics.
- AI in biology includes companies like Recursion and EvolutionaryScale, while AI in robotics focuses on training data repositories for robots.
Lux Capital venture capitalist Josh Wolfe believes that in the future, people will be very bullish on investing in AI sectors, specifically focusing on biology and robotics. In the field of biology, AI is being used to analyze complex biological data and create biologically meaningful relationships. Companies like Recursion and EvolutionaryScale are at the forefront of AI in biology, with EvolutionaryScale using large language models to create proteins that have never existed in nature.
On the robotics side, Wolfe predicts that the value lies in data repositories for training robots rather than creating humanoid robots. He believes that highly specialized robots that excel in specific tasks will be the future of robotics. While humanoid robots may attract attention, Wolfe sees more value in robots that can operate in diverse environments based on data intelligence.
Overall, Wolfe sees a bright future for AI investments in biology and robotics, with a focus on leveraging AI technology to solve complex problems and create innovative solutions in these sectors.
